Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Study of Clinical Treatment of Multiple Myeloma Based on Analytical Omics

NCT04678089 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT04678089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04678089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Study of Clinical Treatment of Multiple Myeloma Based on Analytical Omics
Lead sponsor
Beijing Chao Yang Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 16, 2019
Completion date
December 31, 2023
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bortezomib, multiple myeloma